Researchers from the Children’s Hospital of Philadelphia (CHOP) have uncovered a biomarker that can be detected in the blood up to four years before high-grade ovarian cancer (HGOC) is typically diagnosed. This discovery can potentially be a “game-changer” in early detection of ovarian cancer and could advance pediatric cancer research as well. Overview of Ovarian … Read more
New research from Canada shows that preventive mastectomies can reduce the risks of breast cancer in women with certain forms of BRCA genes that, without intervention, significantly increase the risk of breast cancer. Mutations Raise Risk Every human has both the BRCA1 and BRCA2 genes. However, sometimes these genes become damaged or change in some … Read more
With the discovery of the BRCA gene in December 1995, researchers have been able to gain valuable insights and a better understanding of the role it plays in terms of the development of cancer. We inherit two copies of the BRCA gene in every one of our cells, one from our father and one from … Read more
Every day, there are millions of women around the world who are at risk of getting ovarian cancer – many don’t know they are at risk, while a small percentage are unaware that they already have it. However, in the past few years, science has continued to lead the way through medical research and advancements … Read more
What are BRCA1 and BRCA2 mutated genes? Who is at risk? What does prevention/counseling look like for those with the mutation?
Genetic testing is often a controversial issue, but according to the mainstream medical community, it can save lives. It can even prevent cancer.
Tackling Genetic Risk Factors for Cancer Around 4,500 women in Israel are diagnosed with cancer every year, and between 5% to 10% of the women diagnosed with breast cancer are genetically predisposed towards it – the most common cause is a genetic mutation in the BRCA1 or BRCA2 gene. While this genetic change is found … Read more